These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 19591831)

  • 1. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection.
    Dunn C; Peppa D; Khanna P; Nebbia G; Jones M; Brendish N; Lascar RM; Brown D; Gilson RJ; Tedder RJ; Dusheiko GM; Jacobs M; Klenerman P; Maini MK
    Gastroenterology; 2009 Oct; 137(4):1289-300. PubMed ID: 19591831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.
    Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG
    J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B.
    Gu Y; Lian Y; Zheng Q; Huang Z; Gu L; Bi Y; Li J; Huang Y; Wu Y; Chen L; Huang Y
    BMC Infect Dis; 2020 Jul; 20(1):509. PubMed ID: 32664850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.
    Fisicaro P; Valdatta C; Boni C; Massari M; Mori C; Zerbini A; Orlandini A; Sacchelli L; Missale G; Ferrari C
    Gut; 2009 Jul; 58(7):974-82. PubMed ID: 19201769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate and adaptive immunity associated with resolution of acute woodchuck hepatitis virus infection in adult woodchucks.
    Suresh M; Czerwinski S; Murreddu MG; Kallakury BV; Ramesh A; Gudima SO; Menne S
    PLoS Pathog; 2019 Dec; 15(12):e1008248. PubMed ID: 31869393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK Cells Help Induce Anti-Hepatitis B Virus CD8+ T Cell Immunity in Mice.
    Zheng M; Sun R; Wei H; Tian Z
    J Immunol; 2016 May; 196(10):4122-31. PubMed ID: 27183639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B.
    Micco L; Peppa D; Loggi E; Schurich A; Jefferson L; Cursaro C; Panno AM; Bernardi M; Brander C; Bihl F; Andreone P; Maini MK
    J Hepatol; 2013 Feb; 58(2):225-33. PubMed ID: 23046671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-15 suppresses hepatitis B virus replication via IFN-β production in a C57BL/6 mouse model.
    Yin W; Xu L; Sun R; Wei H; Tian Z
    Liver Int; 2012 Sep; 32(8):1306-14. PubMed ID: 22380514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections.
    Stacey AR; Norris PJ; Qin L; Haygreen EA; Taylor E; Heitman J; Lebedeva M; DeCamp A; Li D; Grove D; Self SG; Borrow P
    J Virol; 2009 Apr; 83(8):3719-33. PubMed ID: 19176632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues.
    Boni C; Vecchi A; Rossi M; Laccabue D; Giuberti T; Alfieri A; Lampertico P; Grossi G; Facchetti F; Brunetto MR; Coco B; Cavallone D; Mangia A; Santoro R; Piazzolla V; Lau A; Gaggar A; Subramanian GM; Ferrari C
    Gastroenterology; 2018 May; 154(6):1764-1777.e7. PubMed ID: 29378197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
    Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
    Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune and viral profile from tolerance to hepatitis B surface antigen clearance: a longitudinal study of vertically hepatitis B virus-infected children on combined therapy.
    Carey I; D'Antiga L; Bansal S; Longhi MS; Ma Y; Mesa IR; Mieli-Vergani G; Vergani D
    J Virol; 2011 Mar; 85(5):2416-28. PubMed ID: 21147914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection.
    Manickam C; Rajakumar P; Wachtman L; Kramer JA; Martinot AJ; Varner V; Giavedoni LD; Reeves RK
    J Virol; 2016 Oct; 90(20):9153-62. PubMed ID: 27489267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B infection.
    Li J; Han Y; Jin K; Wan Y; Wang S; Liu B; Liu Y; Lu S; Huang Z
    Virol J; 2011 May; 8():199. PubMed ID: 21535873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural Killer p46 Controls Hepatitis B Virus Replication and Modulates Liver Inflammation.
    Li W; Jiang Y; Wang X; Jin J; Qi Y; Chi X; Zhang H; Feng X; Niu J
    PLoS One; 2015; 10(8):e0135874. PubMed ID: 26291078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B.
    Lau GK; Cooksley H; Ribeiro RM; Powers KA; Shudo E; Bowden S; Hui CK; Anderson J; Sorbel J; Mondou E; Rousseau F; Lewin S; Perelson AS; Locornini S; Naoumov NV
    Antivir Ther; 2007; 12(5):705-18. PubMed ID: 17713154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen.
    Jegaskanda S; Ahn SH; Skinner N; Thompson AJ; Ngyuen T; Holmes J; De Rose R; Navis M; Winnall WR; Kramski M; Bernardi G; Bayliss J; Colledge D; Sozzi V; Visvanathan K; Locarnini SA; Kent SJ; Revill PA
    J Virol; 2014 Sep; 88(18):10412-20. PubMed ID: 24872585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice.
    Li F; Wei H; Wei H; Gao Y; Xu L; Yin W; Sun R; Tian Z
    Gastroenterology; 2013 Feb; 144(2):392-401. PubMed ID: 23103614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine and chemokine responses in the acute phase of hepatitis B virus replication in naive and previously vaccinated blood and plasma donors.
    Keating SM; Heitman JD; Wu S; Deng X; Stramer SL; Kuhns MC; Mullen C; Norris PJ; Busch MP
    J Infect Dis; 2014 Mar; 209(6):845-54. PubMed ID: 24158960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.